ADPHC, AstraZeneca forge strategic partnership to enhance COPD awareness, care in Abu Dhabi
ABU DHABI (WAM)The Abu Dhabi Public Health Centre (ADPHC) and AstraZeneca FZ LLC (AstraZeneca) have signed a Memorandum of Understanding (MoU) to launch a collaborative public health project to strengthen public health initiatives, and improve outcomes for patients with chronic obstructive pulmonary disease (COPD) in Abu Dhabi emirate.
The MoU was signed on May 13 2025, by Dr. Omniyat Al Hajeri, Executive Director of Community Health sector, representing ADPHC, and Sameh El Fangary. Cluster President GCC, AstraZeneca, representing global biopharmaceutical AstraZeneca, during the 25th IUHPE World Conference on Health Promotion, taking place from May 13 to 16, 2025, at the Abu Dhabi National Exhibition Centre (ADNEC). Dr. Rashed Alsuwaidi, Director General of ADPHC said, "This partnership reflects our steadfast commitment to improving population health in Abu Dhabi through proactive and innovative approaches. By partnering with AstraZeneca, we aim to deliver comprehensive solutions that raise public awareness, promote early screening, and enable best-in-class care for COPD patients. This initiative builds upon the recommendations from the Abu Dhabi Public Health System Sustainability and Resilience (PHSSR) report and strengthens our vision of a healthier Abu Dhabi."Sameh El Fangary, Cluster President GCC, AstraZeneca shared, "Our most recent collaboration with ADPHC is a significant milestone in advancing public health and addressing the rising burden of chronic respiratory diseases in the UAE. Through this MoU, we are proud to support the UAE's healthcare priorities by sharing global best practices, driving education, and enabling early diagnosis and treatment pathways. Together, we are working towards a future where every patient has the opportunity to achieve better health outcomes and an improved quality of life."The strategic agreement outlines a shared vision between ADPHC and AstraZeneca to enhance population health through coordinated efforts centred around disease awareness, prevention, and best practice sharing. This shared vision will significantly benefit COPD patients in Abu Dhabi.The two-year partnership aligns with the company's mission to transform healthcare, and improve patient outcomes, through evidence-based and collaborative approaches.The strategic alliance focuses on three key pillars:-Disease Awareness: Jointly creating and executing public awareness campaigns to educate the community about COPD. This will include online and offline initiatives to encourage routine testing and early screening.-Disease Prevention: Developing early detection strategies to identify COPD in its initial stages, enabling timely intervention and management to reduce the long-term health burden on individuals and the healthcare system.-Best Practice Sharing: Utilising AstraZeneca's global insights and best practices in diagnostics and disease management to enhance patient care in Abu Dhabi. This may include workshops, knowledge exchange sessions with other AstraZeneca affiliates, and collaboration with international partners.A joint task force will be established, with ADPHC and AstraZeneca representatives to oversee the project's execution. The task force will be responsible for aligning strategic priorities, evaluating feasibility, and tracking the progress of each initiative under the Mou. All agreed-upon projects will be subject to further detailed documentation, and the implementation will proceed upon mutual approval from both parties' leadership.ADPHC, which is dedicated to elevating community health through innovation and integrated public health systems, continues to build on its commitment to address non-communicable diseases, including cancer and respiratory illnesses. As part of its broader public health strategy, ADPHC launched the Abu Dhabi Public Health Sustainability and Resilience (PHSSR) report, emphasising the need for early screening and legislative support to combat chronic diseases.AstraZeneca, a global leader in addressing non-communicable diseases (NCDs) in oncology, cardiovascular, renal, and metabolic diseases (CVRM), respiratory conditions such as COPD, and rare diseases, brings unparalleled expertise to the collaboration.
This partnership is a testament to the unwavering commitment of both ADPHC and AstraZeneca to improving public health in Abu Dhabi, and advancing innovative solutions for chronic disease management.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
5 hours ago
- Khaleej Times
Dr Manoj K. Menon named ‘AI & Healthcare Solutions Expert of the Year' at Global Fluxx Awards
Dr Manoj Menon, Group CEO of ACCRO, UAE, and ASHCONN, Qatar, has been named AI and Healthcare Solutions Expert of the Year for the region at the Global Fluxx Awards in Hong Kong. The award recognises leaders selected from over 500 global nominees across 15 countries, highlighting the region's emergence as a healthcare technology hub. Dr Menon brings 34 years of experience in healthcare technology to his current role. His career spans the GCC, USA, Spain, Australia, and India, including positions with HP, Boston Medical Centre, and GE Imaging. He holds multiple patents and has published academic papers in scientific journals while presenting at global healthcare conferences. "The GCC region represents a suitable environment for healthcare innovation," said Dr Menon. "Our goal is to develop AI tools that augment human capabilities, allowing healthcare professionals to enhance their practice across the region." Dr Menon has contributed to healthcare policy frameworks at the national level, developing guidelines that balance innovation with regulatory compliance while maintaining standards of patient safety and data security. He developed Axora, a revenue cycle management platform that uses AI to transform healthcare providers' financial operations. The platform combines predictive analytics with automation to optimise revenue capture, reduce claim denials, and enhance healthcare institutions' economic performance. The recognition aligns with regional AI strategy and ongoing healthcare digitization initiatives.
Zawya
a day ago
- Zawya
Oman to produce medical diagnostic machines locally
A strategic Memorandum of Understanding (MoU) was signed by Dr Mohammad Mahmoodi, CEO of Carbon Technologies, and Dr Frank Vitzthum, Board Member and CTO of R-Biopharm, Germany, in the presence of Dr Rahma bint Ibrahim al Mahrouqiyah, Minister of Higher Education, Research and Innovation, on Tuesday. Under the MoU, advanced diagnostic manufacturing will be localised in Oman, supporting technology transfer and enhancing the country's health innovation ecosystem. The partnership will enable integration of state-of-the-art assay technologies into its local production lines, supporting both national and regional healthcare priorities. 'It is a milestone MoU in Oman's journey towards eliminating tuberculosis and other diseases from the country, and both communicable diseases and NCDs,' said Dr Rahma bint Ibrahim al Mahrouqiyah, Minister of Higher Education, Research and Innovation. 'I'm optimistic and this will pave the way for various scientific advancements in the country, especially when it is located near SQU and within the Innovation Park Muscat. We have begun, and we look forward to having an international consortium to eradicate both communicable and non-communicable diseases. We look forward to collaborating with regional, national and international partners so that we can cooperate with the leading players,' she added. Speaking to the Observer, Dr Mohammad Mahmoudi, Chief Executive Officer of Carbon Technologies, said that this collaboration is a testament to Oman's growing capacity in innovation-driven industries and its strategic openness to global partnerships. 'Together with R-Biopharm, we aim to elevate diagnostic standards, nurture Omani talent and contribute to national healthcare resilience,' Dr Mohammad added. Aligned with the objectives of Oman Vision 2040, the MoU supports national goals in biotechnology, scientific research and industrial innovation. Speaking on the sidelines of the signing ceremony, Eng Said bin Nasser al Salmi, Board Member of Carbon Technologies, said that the MoU would open up more opportunities to leverage Carbon Technologies as a leading Omani company and expand local R&D capabilities to serve both domestic and international markets in the healthcare industry and position Oman among the leading innovation hubs in such sectors. Dr Dirk Dressler, Head of Business Development at R-Biopharm AG, said, 'We are honoured to partner with Oman's Carbon Technologies. This collaboration reflects our confidence in Oman's capabilities and our shared commitment to delivering high-quality, accessible diagnostics across the region." 2025 © All right reserved for Oman Establishment for Press, Publication and Advertising (OEPPA) Provided by SyndiGate Media Inc. (
Gulf Business
3 days ago
- Gulf Business
Saudi's new food establishment rules: What's next for restaurants?
Image credit: Getty Images On August 10, Saudi Arabia's Ministry of Municipalities and Housing adopted updated municipal requirements aimed at regulating food establishments across the kingdom. The move is part of a broader effort to create an integrated operational environment that aligns with public health and safety standards. The new regulations apply to five categories of food businesses: restaurants that prepare and serve meals on-site and for delivery, cafes serving beverages and snacks, cloud kitchens focused on online orders, and food kiosks operating in malls and markets. Read- The requirements mandate compliance with the Saudi Building Code, covering electrical systems, ventilation, air conditioning, and sanitation. They also specify safety features such as non-slip flooring, fire- and moisture-resistant ceilings, and efficient drainage systems. Employees must wear professional attire, carry identification cards, maintain personal hygiene, and avoid using facilities for residential purposes. Smoking is banned indoors except in designated areas, The ministry emphasised that these measures are designed to enhance regulatory oversight, standardise procedures, and improve the overall experience for visitors and beneficiaries. These updates are part of ongoing efforts to elevate operational standards across various sectors. Food labelling regulations to improve consumer awareness Earlier this year, the Saudi Food and Drug Authority (SFDA) announced new technical regulations to improve transparency in the food industry and empower consumers with detailed nutritional information. Starting July 1, 2025, all food establishments will be required to display nutritional details on menus—both physical and online—as well as on digital food ordering platforms. These regulations will include a 'saltshaker' icon next to meals high in sodium, Three key technical regulations to promote healthy dietary habits On February 27, 2025, Caffeine content disclosure: Restaurants and cafes must clearly label the caffeine content of beverages on menus, specifying milligrams per 100ml or per cup. A statement will remind consumers that the maximum recommended daily caffeine intake for adults is 400mg. To assist consumers, the SFDA launched an High salt content labeling: Menu items containing over 5 grams of salt (2,000mg sodium) must be marked with a 'Salt' icon on all menus and online ordering platforms. This measure aims to raise awareness of high-sodium foods and reduce excessive salt consumption linked to various health issues. Physical activity calorie burn labelling: Menus must indicate the estimated time required to burn the calories from each menu item through physical activity. Illustrative icons will show the type and duration of activity needed, helping consumers better understand the energy impact of their food choices. These initiatives reflect the SFDA's preventative strategy to increase life expectancy and lower the burden of diet-related diseases in the country. Coordinated approach to enhancing food safety and nutrition Together, the Ministry of Municipalities and Housing and the SFDA's recent measures mark a significant step forward in Saudi Arabia's efforts to improve food safety, transparency, and public health. By introducing rigorous building and operational standards alongside comprehensive nutritional labeling requirements, the government is addressing multiple facets of food consumption, from hygiene and infrastructure to informed dietary choices. As Saudi Arabia continues its Vision 2030 reforms, these integrated regulations serve not only to protect consumers but also to encourage healthier lifestyles, reduce chronic disease prevalence, and elevate service standards within the food industry. Food establishments across the country will need to adapt to these new rules by mid-2025 to ensure compliance and support the nation's long-term health objectives.
